CYP 2.13% 24.0¢ cynata therapeutics limited

Ann: Letter to Optionholders, page-78

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    Disagree, it just proves a lot of things we have said about MSB for years.
    Too much BS, Too much Faith

    Well, we are about to see soon enough Davisite, MSBs / SIs pom pom brigade might finally pull their big heads in.....

    OA is a 440 patient P3, double blinded trial (that has started pilot already) and the largest stem cell trial of it's kind in OA, and well as of course being a world first Phase 3 in IPSC derived MSCs

    Cynata has 13 indications and 7 ready or getting ready for Phase 2 also.
    Cynata has a tiny market cap, with soon to be circa $32m to ramp up trials.

    It can't drop like MSB from great heights and wipe out billions.

    Risk Reward here is much better even now imo from $100m
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.